BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2867789)

  • 1. Performance deficit induced by low doses of dopamine agonists in rats. Toward a model for approaching the neurobiology of negative schizophrenic symptomatology?
    Carnoy P; Soubrie P; Puech AJ; Simon P
    Biol Psychiatry; 1986 Jan; 21(1):11-22. PubMed ID: 2867789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral deficits induced by low doses of apomorphine in rats: evidence for a motivational and cognitive dysfunction which discriminates among neuroleptic drugs.
    Carnoy P; Ravard S; Wemerman B; Soubrie P; Simon P
    Pharmacol Biochem Behav; 1986 Sep; 25(3):503-9. PubMed ID: 2877466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amisulpride: a review of its use in the management of schizophrenia.
    Curran MP; Perry CM
    Drugs; 2001; 61(14):2123-50. PubMed ID: 11735643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.
    Schremmer C; Morgenstern R; Fink H; Ott T
    Psychopharmacology (Berl); 1990; 100(3):399-403. PubMed ID: 1969173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of dopamine research in schizophrenia.
    Pani L
    Curr Med Res Opin; 2002; 18 Suppl 3():s3-7. PubMed ID: 12418605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors.
    Walters JR; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):5-14. PubMed ID: 13315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of different dopamine receptors in rat diphasic motility response to apomorphine.
    Vaccheri A; Dall'Olio R; Gandolfi O; Montanaro N
    Psychopharmacology (Berl); 1986; 89(3):265-8. PubMed ID: 2873607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia.
    Kasper S
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S19-26. PubMed ID: 12685918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of the pharmacological properties of sultopride sulpiride and other antipsychotic drugs: influence of sultopride, sulpiride and other antipsychotic drugs on spontaneous locomotor activity and changes in locomotor activity induced by apomorphine and clonidine in mice].
    Horikomi K; Fujita M
    Yakubutsu Seishin Kodo; 1986 Sep; 6(3):339-52. PubMed ID: 2880435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of the amphetamine cue by both classical and atypical antipsychotic drugs.
    Nielsen EB; Jepsen SA
    Eur J Pharmacol; 1985 May; 111(2):167-76. PubMed ID: 2862045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation by low doses of selected neuroleptics of food-induced conditioned place preference in rats.
    Guyon A; Assouly-Besse F; Biala G; Puech AJ; Thiébot MH
    Psychopharmacology (Berl); 1993; 110(4):460-6. PubMed ID: 7870917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The place of amisulpride in the atypical neuroleptic class].
    Perrault G; Schoemaker H; Scatton B
    Encephale; 1996 Jun; 22 Spec No 2():3-8. PubMed ID: 8767034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of negative symptoms in schizophrenia with amisulpride.
    Boyer P; Lecrubier Y; Puech AJ; Dewailly J; Aubin F
    Br J Psychiatry; 1995 Jan; 166(1):68-72. PubMed ID: 7894879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-2 selective receptor antagonists suppress sucrose sham feeding in the rat.
    Schneider LH; Gibbs J; Smith GP
    Brain Res Bull; 1986 Oct; 17(4):605-11. PubMed ID: 2946362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of dopamine receptor antagonists on the sexual behavior of male rats.
    Pfaus JG; Phillips AG
    Psychopharmacology (Berl); 1989; 98(3):363-8. PubMed ID: 2568656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine autoreceptor and postsynaptic receptor blocking potency of neuroleptics.
    Kendler KS; Bracha HS; Davis KL
    Eur J Pharmacol; 1982 Apr; 79(3-4):217-23. PubMed ID: 6124428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1639-43. PubMed ID: 2874567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats.
    Duarte C; Biala G; Le Bihan C; Hamon M; Thiébot MH
    Psychopharmacology (Berl); 2003 Feb; 166(1):19-32. PubMed ID: 12525958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM; Elands J; Király I; Wolterink G
    Eur J Pharmacol; 1989 Aug; 166(3):441-52. PubMed ID: 2572429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.